Madison Frazier

ORCID: 0009-0008-2638-5187
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pain Management and Placebo Effect
  • Acupuncture Treatment Research Studies
  • Parasitic Diseases Research and Treatment
  • Complementary and Alternative Medicine Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Long-Term Effects of COVID-19
  • Respiratory Support and Mechanisms
  • Health and Well-being Studies
  • Healthcare and Venom Research
  • Radiopharmaceutical Chemistry and Applications
  • Pharmacy and Medical Practices
  • Epilepsy research and treatment
  • Telomeres, Telomerase, and Senescence
  • COVID-19 and Mental Health
  • Schizophrenia research and treatment
  • Intensive Care Unit Cognitive Disorders
  • Medical Imaging Techniques and Applications
  • Genetics, Aging, and Longevity in Model Organisms
  • CRISPR and Genetic Engineering
  • Parasites and Host Interactions
  • Radiation Detection and Scintillator Technologies

Duke University
2025

Institute of Accelerating Systems and Applications
2022-2023

Morehead State University
2021

Susanna Naggie David R. Boulware Christopher J. Lindsell Thomas G. Stewart Nina T. Gentile and 95 more Sean P. Collins Matthew W. McCarthy Dushyantha Jayaweera Mario Castro Mark Sulkowski Kathleen M. McTigue Florence Thicklin G. Michael Felker Adit A. Ginde Carolyn T. Bramante Alex Slandzicki Ahab Gabriel Nirav Shah Leslie Lenert Sarah E. Dunsmore Stacey J. Adam Allison DeLong George J. Hanna April Remaly Rhonda Wilder Sybil Wilson Elizabeth Shenkman Adrian F. Hernandez William Vincent Raina Vincent Ray Bianchi Jen Premas Diana Cordero-Loperena E. M. Rivera Madhu Gupta Greg Karawan Carey Ziomek Joseph Arena Sonaly DeAlmeida Soroush Ramin Jaya Nataraj Michael K. Paasche‐Orlow Lori Henault Katie Waite David Miller Ginger Brounce Constance George-Adebayo Adeolu Adebayo Jessica Wallan Alex Slandzicki Claudia Vogel Sebastian Munoz David Kavtaradze Cassandra Watson David Singleton Maria Rivon Amanda Sevier Arnold Del Pilar Amber Spangler Sohail Rao Luis Cantu Arvind Krishna Kathy Evans Tylene Falkner Brandi Kerr Robert Spees Mailyn Marta G. Michael Felker Amanda Harrington Rowena J Dolor Madison Frazier Lorraine Vergara Jessica Wilson Valencia Burruss Terri Hurst Igho Ofotokun Laurel Bristow Rajesh Prabhu Krystal Klicka Amber Lightfeather Vicki James Marcella Rogers Pradeep Parihar De'Ambra Torress Chukwuemeka Oragwu Ngozi Oguego Rajesh Pillai Mustafa Juma Ahab Gabriel Emad Ghaly Dafer Al-Haddadin Courtney Ramirez Gammal Hassanien Samah Ismail Andrew Meltzer Seamus Moran Scott Brehaut Angelina Roche Manisha Mehta Nicole Koppinger

The effectiveness of ivermectin to shorten symptom duration or prevent hospitalization among outpatients in the US with mild moderate symptomatic COVID-19 is unknown.To evaluate efficacy ivermectin, 400 μg/kg, daily for 3 days compared placebo treatment early COVID-19.ACTIV-6, an ongoing, decentralized, double-blind, randomized, placebo-controlled platform trial, was designed repurposed therapies COVID-19. A total 1591 participants aged 30 years and older confirmed COVID-19, experiencing 2...

10.1001/jama.2022.18590 article EN JAMA 2022-10-21
Matthew W. McCarthy Susanna Naggie David R. Boulware Christopher J. Lindsell Thomas G. Stewart and 95 more G. Michael Felker Dushyantha Jayaweera Mark Sulkowski Nina T. Gentile Carolyn T. Bramante Upinder Singh Rowena J Dolor Juan Ruiz-Unger Sybil Wilson Allison DeLong April Remaly Rhonda Wilder Sean P. Collins Sarah E. Dunsmore Stacey J. Adam Florence Thicklin George J. Hanna Adit A. Ginde Mario Castro Kathleen M. McTigue Elizabeth Shenkman Adrian F. Hernandez William Vincent Raina Vincent Ray Bianchi Jen Premas Diana Cordero-Loperena Evelyn Rivera Madhu Gupta Greg Karawan Carey Ziomek Joseph Arena Sonaly DeAlmeida Soroush Ramin Jaya Nataraj Michael K. Paasche‐Orlow Lori Henault Katie Waite David Miller Ginger Brounce Constance George-Adebayo Adeolu Adebayo Jessica Wallan Claudia Vogel Sebastian Munoz David Kavtaradze Cassandra Watson David Singleton Maria Rivon Amanda Sevier Arnold Del Pilar Amber Spangler Sohail Rao Luis Cantu Arvind Krishna Kathy Evans Tylene Falkner Brandi Kerr Robert Spees Mailyn Marta Amanda Harrington Madison Frazier Lorraine Vergara Jessica Wilson Valencia Burruss Terri Hurst Igho Ofotokun Laurel Bristow Rajesh Prabhu Krystal Klicka Amber Lightfeather Vicki James Marcella Rogers Pradeep Parihar De'Ambra Torress Chukwuemeka Oragwu Ngozi Oguego Rajesh Pillai Mustafa Juma Emad Ghaly Dafer Al-Haddadin Courtney Ramirez Gammal Hassanien Samah Ismail Andrew Meltzer Seamus Moran Scott Brehaut Angelina Roche Manisha Mehta Nicole Koppinger Jose Baez Ivone Pagan Dallal Abdelsayed Mina Aziz Philip A. Robinson Julie Nguyen

Importance The effectiveness of fluvoxamine to shorten symptom duration or prevent hospitalization among outpatients with mild moderate symptomatic COVID-19 is unclear. Objective To evaluate the efficacy low-dose (50 mg twice daily) for 10 days compared placebo treatment in US. Design, Setting, and Participants ongoing Accelerating Therapeutic Interventions Vaccines (ACTIV-6) platform randomized clinical trial was designed test repurposed medications COVID-19. A total 1288 participants aged...

10.1001/jama.2022.24100 article EN JAMA 2023-01-12
Susanna Naggie David R. Boulware Christopher J. Lindsell Thomas G. Stewart Alex Slandzicki and 95 more Stephen C. Lim Jonathan B. Cohen David Kavtaradze Arch Amon Ahab Gabriel Nina T. Gentile G. Michael Felker Dushyantha Jayaweera Matthew W. McCarthy Mark Sulkowski Russell L. Rothman Sybil Wilson Allison DeLong April Remaly Rhonda Wilder Sean P. Collins Sarah E. Dunsmore Stacey J. Adam Florence Thicklin George J. Hanna Adit A. Ginde Mario Castro Kathleen M. McTigue Elizabeth Shenkman Adrian F. Hernandez William Vincent Raina Vincent Ray Bianchi Jen Premas Diana Cordero-Loperena E. M. Rivera Madhu Gupta Greg Karawan Carey Ziomek Joseph Arena Sonaly DeAlmeida Soroush Ramin Jaya Nataraj Michael K. Paasche‐Orlow Lori Henault Katie Waite David Miller Ginger Brounce Constance George-Adebayo Adeolu Adebayo Jessica Wallan Claudia Vogel Sebastian Munoz Cassandra Watson David Singleton Maria Rivon Amanda Sevier Arnold Del Pilar Amber Spangler Sohail Rao Luis Cantu Arvind Krishna Kathy Evans Tylene Falkner Brandi Kerr Robert Spees Mailyn Marta Amanda Harrington Rowena J Dolor Madison Frazier Lorraine Vergara Jessica Wilson Valencia Burruss Terri Hurst Igho Ofotokun Pauline Rebolledo Rajesh Prabhu Krystal Klicka Amber Lightfeather Vicki James Marcella Rogers Pradeep Parihar De'Ambra Torress Chukwuemeka Oragwu Ngozi Oguego Rajesh Pillai Mustafa Juma Emad Ghaly Dafer Al-Haddadin Courtney Ramirez Gammal Hassanien Samah Ismail Andrew Meltzer Seamus Moran Scott Brehaut Angelina Roche Manisha Mehta Nicole Koppinger Jose Baez Ivone Pagan

It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients mild to moderate COVID-19.

10.1001/jama.2023.1650 article EN JAMA 2023-02-20

Study objectiveAcute musculoskeletal pain in emergency department (ED) patients is frequently severe and challenging to treat with medications alone. The purpose of this study was determine the feasibility, acceptability, effectiveness adding ED acupuncture acute episodes neck, back, extremities.MethodsIn pragmatic 2-stage adaptive open-label randomized clinical trial, Stage 1 identified whether auricular (AA; based on battlefield protocol) or peripheral (PA; needles head, extremities only),...

10.1016/j.annemergmed.2024.03.014 article EN cc-by Annals of Emergency Medicine 2024-05-22

Objective Acupuncture is an evidence-based pain treatment in clinic settings, but its optimal delivery has not been established emergency departments (EDs). As part of adaptive pragmatic randomized controlled trial ED acupuncture for acute musculoskeletal (NCT04290741), we embedded a qualitative evaluation acceptability and suggestions improvement from study participants receiving the ED. Methods Semi-structured interviews conducted remotely evaluated factors impacting patients’...

10.1371/journal.pone.0318345 article EN public-domain PLoS ONE 2025-02-12

Telomerase is a ribonucleoprotein enzyme complex that maintains telomeres at the ends of linear eukaryotic chromosomes. minimally requires telomerase reverse transcriptase (TERT) protein uses non-coding RNA as template to extend 3ʹ lagging strands. In addition binding TERT and providing template, plays additional roles in accessory proteins contributing catalysis. RNAs are rapidly evolving length, sequence structure, making phylogenetic comparisons challenging limiting our understanding...

10.1096/fasebj.2021.35.s1.04348 article EN The FASEB Journal 2021-05-01
Coming Soon ...